• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: OGDEN MANUFACTURING PLANT OPTIFLUX 180NRE DIALYZER FINISHED ASSY.; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

OGDEN MANUFACTURING PLANT OPTIFLUX 180NRE DIALYZER FINISHED ASSY.; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM Back to Search Results
Catalog Number 0500318E
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Abdominal Pain (1685); Chest Pain (1776); Diarrhea (1811); Hemorrhage/Bleeding (1888); Nausea (1970); Vomiting (2144); Hot Flashes/Flushes (2153)
Event Date 08/28/2023
Event Type  Injury  
Event Description
Fresenius received a voluntary medwatch (mw5145376) report stating that a hemodialysis (hd) patient utilizing an optiflux f180nre dialyzer began complaining of nausea, vomiting, diarrhea, abdominal pain, chest tightness, and flushing within minutes of hd treatment initiation.Additional information was obtained through follow-up with the clinical nurse manager.The patient arrived for a regularly scheduled four-hour hd treatment.The patient¿s treatment was initiated at 1200 hours.Within the first minute of treatment start, the patient complained of nausea, vomiting, diarrhea, abdominal pain, chest tightness, and flushing.The treatment was discontinued, and time noted at 1200 hours.The patient¿s blood was not rinsed back, and the estimated blood loss was 100ml.The patient was administered ondansetron 4mg intravenous push (ivp) and diphenhydramine 50mg ivp.The patient recovered on site and was discharged home in stable condition.The patient resumed treatment on a subsequent date with an optiflux f180nr dialyzer without incident.The f180nre dialyzer was added as an allergy to the patient¿s medical history.This event was classified as a dialyzer reaction.The patient does not require any additional pre-treatment medication with the f180nr dialyzer.The dialyzer is to be flushed with saline per protocol.No sample was expected to be returned for evaluation.
 
Manufacturer Narrative
Clinical investigation: based on the available information, there is a temporal and likely causal relationship between the fresenius opitflux f180nre dialyzer and the patient¿s reaction (characterized by nausea, vomiting, diarrhea, abdominal pain, chest tightness, and flushing).Although rare, hypersensitivity or anaphylactoid reactions to dialyzers are a known risk during hemodialysis.The exposure of the patient¿s blood to a foreign substance present in the extracorporeal circuit is the result of an immunoallergic response.Type a reactions usually begin in the first few minutes of dialysis and are associated with symptoms such as itching, burning sensation at the access site, urticaria, flushing, cough, sneezing, wheezing, abdominal cramps, diarrhea, headache, back and chest pain, nausea, vomiting, fever, and chills.Although the patient experienced an adverse reaction during treatment, there is no allegation of a product malfunction or deficiency related to this event.Plant investigation: no sample was returned for manufacturer evaluation.A production records review was performed on the reported lot.An investigation of the device history records (dhr) was conducted by the manufacturer.There was no indication of product nonacceptance, deviation, non-conformance, rework, labeling or process control failure during the manufacturing process which could be associated with the reported event.The lot met all release criteria.A definitive conclusion regarding the complaint incident cannot be reached with the information provided.Therefore, the complaint was not confirmed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OPTIFLUX 180NRE DIALYZER FINISHED ASSY.
Type of Device
DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM
Manufacturer (Section D)
OGDEN MANUFACTURING PLANT
director, site quality
475 west 13th street
ogden UT 84404
Manufacturer (Section G)
OGDEN MANUFACTURING PLANT
director, site quality
475 west 13th street
ogden UT 84404
Manufacturer Contact
jessica trujillo
920 winter st
waltham, MA 02451
6174175172
MDR Report Key17909050
MDR Text Key325338479
Report Number0001713747-2023-00692
Device Sequence Number1
Product Code KDI
UDI-Device Identifier00840861100156
UDI-Public00840861100156
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K162488
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Company Representative
Reporter Occupation Nurse
Type of Report Initial
Report Date 10/10/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number0500318E
Device Lot Number23JU07018
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Device AgeMO
Initial Date Manufacturer Received Not provided
Initial Date FDA Received10/10/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/31/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Other;
Patient Age49 YR
Patient SexFemale
Patient Weight107 KG
-
-